U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06894862) titled 'A Study of the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants' on March 09.
Brief Summary: The goal of this clinical trial is to learn if investigational drug NYR-BI03 is safe and tolerated when given as an intravenous infusion over 3 hours to healthy male and female volunteers.
The study will also show what if any medical problems participants have when taking drug NYR-BI03 and it will provide information on blood levels of the drug.
Researchers will compare drug NYR-BI03 to a placebo (a similar substance that contains no drug) to see if NYR-BI03 is safe and tolerated.
Participants will be admini...